Liraglutide Side Effects: What to Know Before You Start

Liraglutide can support weight-management care for appropriate patients, but it can also cause side effects. That is true for FDA-approved brand-name products, FDA-approved generic products, and GLP-1 medications generally.

The goal is not to scare you away from treatment. The goal is to help you have a better consult, recognize what is common, and know which safety topics deserve clinician review.

Common side effects

Common side effects with liraglutide can include:

• Nausea
• Diarrhea
• Constipation
• Vomiting
• Headache
• Low appetite
• Indigestion or stomach discomfort

Digestive symptoms are often most noticeable when starting or increasing dose. Your clinician can explain what is expected, what may improve over time, and what should prompt medical attention.

Do not change your dose on your own to "push through" symptoms. Follow the instructions given by your prescriber.

Serious risks to discuss

Liraglutide labeling includes warnings and precautions that should be reviewed before treatment. These can include:

• Thyroid C-cell tumor warning
• Pancreatitis
• Gallbladder disease
• Kidney problems, especially with dehydration
• Low blood sugar risk when used with certain diabetes medications
• Serious allergic reactions
• Increased heart rate
• Possible impacts related to delayed gastric emptying

This is why a real medical history matters. GLP-1 care should not be treated like a cosmetic purchase.

Who should not use liraglutide

People with a personal or family history of medullary thyroid carcinoma should not use liraglutide. People with Multiple Endocrine Neoplasia syndrome type 2 should not use it either. A prior serious hypersensitivity reaction to liraglutide or product components is also a contraindication.

Your clinician may identify other reasons it is not appropriate based on your history.

When to contact a clinician

Ask your clinician what to do if you have:

• Severe or persistent abdominal pain
• Repeated vomiting
• Signs of dehydration
• Symptoms of low blood sugar
• Allergic reaction symptoms
• A lump or swelling in the neck
• Trouble swallowing
• Hoarseness that does not go away
• Severe constipation or inability to keep fluids down

If symptoms are severe or feel urgent, seek emergency care.

Why FDA-approved still does not mean risk-free

FDA-approved means the medication has been reviewed for safety, effectiveness, quality, and labeling for its approved use. It does not mean no side effects exist.

The advantage is that FDA-approved medications have standardized labeling, manufacturing expectations, and post-market safety monitoring. That makes clinician-patient decision-making clearer.

Compounded drugs are different. The FDA says compounded drugs are not FDA-approved and the agency does not verify their safety, effectiveness, or quality before they are marketed.

ClearDay's safety posture

ClearDay connects patients with licensed U.S. clinicians who review whether FDA-approved generic liraglutide may be appropriate. Prescriptions are issued only when clinically appropriate. Medication is dispensed by licensed U.S. pharmacies and is never compounded.

The visit is $49. Medication is separate if prescribed.

Sources

• FDA: Saxenda prescribing information - https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/206321s025lbl.pdf
• FDA: First generic liraglutide referencing Victoza - https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-once-daily-glp-1-injection-lower-blood-sugar-patients-type-2-diabetes
• Mayo Clinic: Liraglutide description and safety information - https://www.mayoclinic.org/drugs-supplements/liraglutide-subcutaneous-route/description/drg-20073828
• FDA: Compounding and the FDA - https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

This article is for general information only and is not medical advice. A licensed clinician must determine whether any prescription medication is appropriate.